International Stem Cell (ISCO) EBT Margin (2010 - 2026)
International Stem Cell (ISCO) reported EBT Margin of -2.58% for Q2 2026, down 7.85 percentage points from 5.27% a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) EBT Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, International Stem Cell's EBT Margin came in at -2.39%, up 0.21 percentage points year-over-year; for FY2025, it came in at -4.59%, down 2.25 percentage points from FY2024.
- EBT Margin has a five-year change of +36.53 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -2.34% in FY2024 (+7.95 pp), -10.30% in FY2023 (-6.41 pp), -3.89% in FY2022 (+24.67 pp) and -28.55% in FY2021 (+12.57 pp).
- Five-year quarterly EBT Margin spans a low of -34.80% in Q3 2021 and a high of 5.27% in Q2 2025.
- Year over year, EBT Margin gained in four of the last seven quarters, with an average year-over-year change of +1.10 percentage points.
- The high point for year-over-year EBT Margin in five years was Q1 2022 (a gain of 35.68 percentage points); the low point was Q4 2023 (a drop of 25.40 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | International Stem Cell | 2.80 Mn | -1.17 Mn | 1.46 Mn | -2.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.58% |
| Dec 31, 2025 | -16.15% |
| Sep 30, 2025 | 2.41% |
| Jun 30, 2025 | 5.27% |
| Mar 31, 2025 | -12.02% |
| Dec 31, 2024 | 0.49% |
| Sep 30, 2024 | -5.74% |
| Jun 30, 2024 | 4.89% |
| Mar 31, 2024 | -10.05% |
| Dec 31, 2023 | -24.25% |
| Sep 30, 2023 | -6.64% |
| Jun 30, 2023 | -9.72% |
| Mar 31, 2023 | -1.63% |
| Dec 31, 2022 | 1.15% |
| Sep 30, 2022 | -19.67% |
| Jun 30, 2022 | -0.10% |
| Mar 31, 2022 | -0.45% |
| Dec 31, 2021 | -19.75% |
| Sep 30, 2021 | -34.80% |
| Jun 30, 2021 | -24.28% |
API Access
International Stem Cell EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();